 |
The Journal of Neuroscience, June 1, 2003, 23(11):4635-4644
Previous Article | Next Article 
Inhibition of the Proteasome by Lactacystin Enhances Oligodendroglial Cell Differentiation
Laura A. Pasquini,
Pablo M. Paez,
Marcos A. N. Besio Moreno,
Juana M. Pasquini, and
Eduardo F. Soto
Departamento de Química Biológica, Instituto de
Química y Fisicoquímica Biológica, Facultad de Farmacia y
Bioquímica, Universidad de Buenos Aires, Consejo Nacional de
Investigaciones Científicas y Técnicas, Buenos Aires 1113,
Argentina
We have used lactacystin, a specific inhibitor of the 26S proteasome, in
oligodendroglial cell (OLGc) primary cultures to explore the possible
participation of the proteasomeubiquitin-dependent pathway in the
decision of the OLGcs to arrest their proliferation and start differentiation.
Addition of lactacystin at various concentrations to cultures containing a
majority of OLGc was found to produce their withdrawal from the cell cycle and
to induce their biochemical and morphological differentiation, with the
appearance of extensive myelin-like sheets. The three classic proteolytic
activities of the proteasome were significantly decreased in the
lactacystin-treated cultures, and the immunocytochemical analysis showed an
increase in the number of O4-, O1-, myelin basic protein-, and myelin
proteolipid protein-positive cells and a decrease in A2B5-reacting cells.
Quantitative immunochemical evaluation of the expression of certain proteins
controlling the cell cycle showed an increase in p27kip1-, cyclin
D-, and cdk4-positive cells, with a decrease in cyclin E- and cdk2-positive
cells. In the lactacystin-treated OLGcs, there was a dose-dependent decrease
in the number of cells incorporating bromodeoxyuridine and in the activity of
the complexes cyclin Dcdk4 and cyclin Ecdk2. Furthermore,
increased levels of expression of several STAT factors were found, suggesting
that proteasome inhibition in OLGcs could stabilize signals of survival and
differentiation that might be processed through the JAK/STAT signaling
cascade.
Key words: oligodendroglial cells; lactacystin; MG132; differentiation; cyclins; p27kip1; JAK/STAT; ubiquitin; proteasome; myelination
Received Aug. 26, 2002;
revised Mar. 12, 2003;
accepted Mar. 19, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
F. Guo, J. Ma, E. McCauley, P. Bannerman, and D. Pleasure
Early Postnatal Proteolipid Promoter-Expressing Progenitors Produce Multilineage Cells In Vivo
J. Neurosci.,
June 3, 2009;
29(22):
7256 - 7270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fujita, S. Sugama, M. Nakai, T. Takenouchi, J. Wei, T. Urano, S. Inoue, and M. Hashimoto
{alpha}-Synuclein Stimulates Differentiation of Osteosarcoma Cells: RELEVANCE TO DOWN-REGULATION OF PROTEASOME ACTIVITY
J. Biol. Chem.,
February 23, 2007;
282(8):
5736 - 5748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Guo, F. Shang, Q. Liu, L. Urim, M. Zhang, and A. Taylor
Ubiquitin-proteasome pathway function is required for lens cell proliferation and differentiation.
Invest. Ophthalmol. Vis. Sci.,
June 1, 2006;
47(6):
2569 - 2575.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|